Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Tamoxifen prevention of breast cancer: an instance of the fingerpost.

Lippman SM, Brown PH.

J Natl Cancer Inst. 1999 Nov 3;91(21):1809-19. Review. No abstract available.

PMID:
10547388
2.

Defining the role of raloxifene for the prevention of breast cancer.

Kalidas M, Hilsenbeck S, Brown P.

J Natl Cancer Inst. 2004 Dec 1;96(23):1731-3. No abstract available.

PMID:
15572750
3.

Prevention of breast cancer: current state of the science and future opportunities.

Uray IP, Brown PH.

Expert Opin Investig Drugs. 2006 Dec;15(12):1583-600. Review.

PMID:
17107283
4.

Tamoxifen, raloxifene and the prevention of breast cancer.

Bentrem DJ, Craig Jordan V.

Minerva Endocrinol. 2002 Jun;27(2):127-39. Review.

PMID:
11961504
5.

Playing the old piano: another tune for endocrine therapy?

Hayes DF.

J Natl Cancer Inst. 2003 Nov 5;95(21):1565-7. No abstract available.

PMID:
14600082
6.

Chemoprevention of breast cancer.

Thomsen A, Kolesar JM.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. doi: 10.2146/ajhp070663. Review.

PMID:
19020189
8.

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

Dunn BK, Ford LG.

Breast J. 2001 May-Jun;7(3):144-57. Review.

PMID:
11469927
9.

[Additional effect of SERM: mammary gland].

Kurebayashi J.

Clin Calcium. 2004 Oct;14(10):47-51. Review. Japanese.

PMID:
15577131
10.

Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?

Wu K, Brown P.

J Natl Cancer Inst. 2003 Jun 4;95(11):766-7. Review. No abstract available.

PMID:
12783921
11.

Breast cancer prevention.

Rodabaugh KJ, Bloss JD.

Clin Obstet Gynecol. 2001 Sep;44(3):478-84. Review. No abstract available.

PMID:
11685873
12.

Breast cancer chemoprevention.

Rosenbaum Smith SM, Osborne MP.

Am J Surg. 2000 Oct;180(4):249-51. Review.

PMID:
11113429
13.

SERMs: meeting the promise of multifunctional medicines.

Jordan VC.

J Natl Cancer Inst. 2007 Mar 7;99(5):350-6. Review.

PMID:
17341726
14.

Progress in the prevention of breast cancer: concept to reality.

Jordan VC.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):269-77. Review.

PMID:
11162935
15.

Tamoxifen versus raloxifene in the prevention of breast cancer.

Wickerham DL.

Eur J Cancer. 2002 Nov;38 Suppl 6:S20-1. No abstract available.

PMID:
12409060
16.

Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.

Vastag B.

J Natl Cancer Inst. 2006 Jun 7;98(11):733-5. No abstract available.

PMID:
16757696
17.

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM.

Clin Cancer Res. 2003 Jan;9(1 Pt 2):495S-501S. Review.

18.

Upstaging tamoxifen? New classes of drugs emerging for breast cancer.

Twombly R.

J Natl Cancer Inst. 2002 Apr 3;94(7):474-5. No abstract available. Erratum in: J Natl Cancer Inst 2002 May 15;94(10):717.

PMID:
11929942
19.
20.

Supplemental Content

Support Center